Catalyst Wire Dossier Catalyst Wire Dossier

Healon5

ophthalmic viscosurgical device (hyaluronate-based; bacterially-derived) · Abbott Medical Optics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Healon5, covering 2009-06-16 to 2018-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD) [NA]

See pricing